Prechewed Labs raises $48M Series B to eliminate chewing
The Kyoto-born nutrition startup led by Theodore Whitlock closed an oversubscribed round at a $420M valuation.
Prechewed Labs, the pre-oral nutrition startup behind The Daily Bolus, has closed a $48M Series B at a $420M post-money valuation, the company confirmed this morning. The round was led by Acre Capital, with participation from Tenzing Partners and a syndicate of founder-operators that the company declined to fully name.
Theodore Whitlock, who founded Prechewed after what he has described as a 'personal productivity crisis' during his last exit, said the funding would be used to scale the company's proprietary Pre-Oral Hydrolysis™ process and expand the Chewing Floor facility outside Los Angeles.
'Chewing is the last unoptimized surface area in a high-performing operator's calendar,' Whitlock said. 'We are building the infrastructure to retire it.'
Prechewed's consumer catalog now includes 28 SKUs, with a flagship product — The Daily Bolus — positioned as an all-day nutritional replacement for traditional meals. The company also operates a waitlist-only premium line, The Founder's Reserve, reportedly priced at $480 per 3-ounce pouch.
Several LPs expressed interest in the company's enterprise tier, which pitches pre-chewed nutrition as a productivity intervention for knowledge-work teams. One source familiar with the round described the enterprise TAM as 'genuinely unbounded,' citing Prechewed's internal estimate of 312 reclaimed jaw-hours per employee per year.
The company declined to disclose revenue but confirmed that it ships to all 50 states and one P.O. box in Kyoto.